Overview
What is Sansum Diabetes Research Institute?
Sansum Diabetes Research Institute, based in Santa Barbara, California, is a dedicated nonprofit organization committed to enhancing the lives of individuals affected by diabetes. For over a decade, the institute has been a global leader in the development of the Artificial Pancreas (AP), collaborating with prestigious institutions like Harvard University, the University of California, Santa Barbara, Mayo Clinic, Mount Sinai Medical Center, and the University of Virginia. The goal of the AP system is to provide automated glucose regulation through controlled insulin delivery in response to detected patterns of change. Sansum provides training and support for patients with Type 1 diabetes who have been prescribed this treatment. The institute is also involved in groundbreaking research, funded by the NIH, studying automated insulin delivery in pregnant women with Type 1 diabetes, a first-of-its-kind study in collaboration with Harvard University and other renowned institutions. Apart from Type 1 diabetes, Sansum is also engaged in researching Type 2 diabetes, under the leadership of their Chief Scientific Officer, Dr. Samuel Klein. This research initiative aims to understand the mechanisms responsible for metabolic alterations associated with cardiometabolic diseases and how specific nutritional interventions can improve metabolic health and decrease the risk of complications. Sansum established the Santa Barbara Nutrition Health Coalition in 2021 to improve the health and well-being of people at high risk for cardiovascular and metabolic diseases living in Santa Barbara County, focusing on innovative community-based, evidence-based nutrition intervention programs.
Official website here: www.sansum.org
Is Sansum Diabetes Research Institute legitimate?
Sansum Diabetes Research Institute is a legitimate nonprofit organization registered as a 501(c)(3) entity. Sansum Diabetes Research Institute submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $817,692
Professional Fundraising Fees: $0
Other Salaries and Wages: $2,557,636
For more financial information, click here
What is the mission statement of Sansum Diabetes Research Institute?
The Sansum Diabetes Research Institute is dedicated to improving the lives of individuals impacted by diabetes through its research, education, and care initiatives. For over a decade, the institute has been a global leader in the development of the artificial pancreas, partnering with renowned institutions to advance automated glucose regulation for people with diabetes. The institute provides training and support for patients using this technology, conducting numerous device research trials each year. In addition to Type 1 diabetes research, the institute has launched a program in precision metabolism, aiming to understand the mechanisms responsible for metabolic alterations associated with cardiometabolic diseases and improve metabolic health. In an effort to combat the high incidence of obesity and Type 2 diabetes in certain communities, Sansum Diabetes Research Institute has launched a research program to evaluate the effectiveness of an innovative, culturally appropriate diet intervention program.
Official website here: www.sansum.org
Who is the CEO of Sansum Diabetes Research Institute?
Ellen Goodstein is the Director Of Research & Innovation of Sansum Diabetes Research Institute.
Official website here: www.sansum.org
What is the revenue of Sansum Diabetes Research Institute?
Sansum Diabetes Research Institute's revenue in 2022 was $8,154,412.
Official website here: www.sansum.org
Who are the executives of Sansum Diabetes Research Institute and what are their salaries?
The average compensation at Sansum Diabetes Research Institute during 2022 was $30,137. There are 112 employees and 42 volunteers at Sansum Diabetes Research Institute.
Here are 27 key members and their salaries:
- David Kerr (Director Of Research & Innovation)
- Kristin Castorino Do (Research Physician)
- Raul Bastarrachea (Senior Scientist)
- Ellen Goodstein (Executive Dir.)
- Kristen Nelson (Clinical Nurse Pra)
- Mei Mei Church (Nurse Practitioner)
- Alexander M Depaoli Md (President) [Trustee/Director]
- Kenneth S Waxman Md Facs (Vice President) [Trustee/Director]
- James Sloan (Treasurer) [Trustee/Director]
- Brad Webb Phd (Secretary) [Trustee/Director]
- Joan Doell Arnold (Trustee)
- Daniel N Berger Md (Trustee)
- Anthony Castillo (Trustee)
- George Emerson (Trustee)
- Miguel Avila (Trustee)
- Kathryn Brewer (Trustee)
- Lindsey Duca Phd (Trustee)
- Elena Engel (Trustee)
- Deborah Gibson Rd Cde (Trustee)
- Norman Kurland (Trustee)
- Michael Paskin (Trustee)
- Matthew Rowe Cima (Trustee)
- Mark Simon (Trustee)
- Steven Jung Esq (Trustee)
- Flint Ogle (Trustee)
- Miguel Rodriguez (Trustee)
- Wendy Thies Sell (Trustee)
Official website here: www.sansum.org
Where can I find the form 990 for Sansum Diabetes Research Institute?
The Sansum Diabetes Research Institute’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.sansum.org
Learn more at the official website: www.sansum.org
Mission Statement of Sansum Diabetes Research Institute
Sansum Diabetes Research Institute is a dedicated organization, committed to improving the lives of individuals impacted by diabetes. Their mission is multifaceted, encompassing research, education, and care. Through rigorous research, Sansum Diabetes Research Institute aims to advance the understanding and treatment of diabetes in all its forms. They have made significant strides in the development of the artificial pancreas, partnering with esteemed institutions to create a system that provides automated glucose regulation. This technology, when prescribed by a physician, is supported by the Institute's trained professionals, who provide education and monitoring to patients with Type 1 diabetes.
In addition to Type 1 diabetes research, Sansum Diabetes Research Institute is also delving into Type 2 diabetes. Under the leadership of their Chief Scientific Officer, Dr. Samuel Klein, they have initiated a program in the science of precision metabolism. This research aims to gain a deeper understanding of the metabolic alterations associated with cardiometabolic diseases and how specific nutritional interventions can improve metabolic health and decrease the risk of complications. Recognizing the high risk of obesity and Type 2 diabetes in certain communities, Sansum Diabetes Research Institute launched a research program in 2022 to evaluate the clinical efficacy of a culturally appropriate diet intervention program designed for socioeconomically disadvantaged adults with obesity and diabetes.
In conclusion, Sansum Diabetes Research Institute is a relentless force in the fight against diabetes. Their mission is to improve the lives of those affected by diabetes through groundbreaking research, innovative education, and compassionate care. Their commitment to understanding and addressing the complexities of diabetes, as well as their dedication to improving health outcomes for underserved communities, sets them apart as a beacon of hope in the field of diabetes research.
Impact
This information is meant to be a general summary of Sansum Diabetes Research Institute. Please take the time to review official sources before making any decisions based upon the content provided here.
Sunday, July 21, 2024
Sansum Diabetes Research Institute's impact is significant in the field of diabetes research. They are dedicated to improving the lives of people impacted by diabetes through groundbreaking research, education, and care.
In the realm of Type 1 diabetes research, SDRI is a global leader in the development of the artificial pancreas. They have partnered with prestigious institutions like Harvard University, Mayo Clinic, and others to innovate and improve the lives of individuals with diabetes. Their research on automated insulin delivery in pregnant women with Type 1 diabetes, funded by the NIH, is pioneering and has the potential to have a lasting impact on diabetes management.
Additionally, SDRI's research in Type 2 diabetes, particularly in the science of precision metabolism, is advancing our understanding of metabolic health and offering new insights into how specific nutritional interventions can improve health outcomes and reduce complications associated with cardiometabolic diseases. Their efforts to launch innovative nutrition programs aimed at high-risk populations, such as the Latino community in Santa Barbara, demonstrate a commitment to addressing health disparities and improving overall well-being.
With a focus on both Type 1 and Type 2 diabetes, SDRI's research programs and clinical studies are at the forefront of diabetes research, contributing to the development and approval of new technologies like the Omnipod 5 AP system. Their work not only advances scientific knowledge but also translates into tangible benefits for individuals living with diabetes.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
Patient Care Fees
Revenue
$46,125
Research Contracts
Revenue
$2,524,311
Organization Details
Founding Year
1944
Phone
(805) 682-7638
Principal Officer
Ellen Goodstein
Main Address
2219 Bath Street, Santa Barbara, CA, 93105
Website
www.sansum.org
NTEE Category
Code: H05 - Medical research
If you are a representative of Sansum Diabetes Research Institute and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.